Scribe Therapeutics Email Format
Biotechnology ResearchCalifornia, United States51-200 Employees
Scribe Therapeutics is a biotechnology research company headquartered at 1150 Marina Village Parkway in Alameda, California 94501, United States, focused on developing genetic medicines through its CRISPR by Design approach to genetic modification. The organization employs between 51 and 200 people. Its lead program, STX-1150, has received clearance from the Australian Therapeutic Goods Administration to initiate a first-in-human clinical study for the treatment of hypercholesterolemia and reduction of low-density lipoprotein cholesterol. Scribe participates in the scientific community through presentations related to its engineered CRISPR platform at industry events, including ASGCT 2026. More information about the company is available on its website, scribetx.com.